Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:12 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Random-start Ovarian Stimulation in Egg-donors (ROSE)
NCT02821819 · Instituto Bernabeu · PHASE4 · terminated · last registry update 2019-08-19 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Difficult recruitment” | – | Registry record, Instituto Bernabeu |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against LHCGR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-07-07Results posted on the registry: Weill Medical College of Cornell University, Letrozole + Letrozole (NCT01035099)
- 2020-02-13Also stopped (terminated): Celldex Therapeutics, CDX-1307 Vaccine Regimen + Chemotherapy (NCT01094496)
- 2020-01-13Phase 3 first posted: American University of Beirut Medical Center, Dual trigger + hCG (standard) (NCT04224818)
- 2019-12-18Also stopped (withdrawn): University of Washington, Testosterone 1% Gel + Acyline (NCT02147964)
- 2019-11-14Phase 3 first posted: Ferring Pharmaceuticals, MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL + MENOPUR powder and solvent for solution for injection, 75 IU (NCT04163458)
- 2019-10-09Results posted on the registry: IBSA Institut Biochimique SA, Urofollitrophin + Follitrophin alpha (NCT01969201)
- 2019-08-12Results posted on the registry: University of California, San Diego, hCG (NCT02145247)
- 2019-08-05Results posted on the registry: IVFarma LLC, Follitropin alfa (Primapur) + Follitropin alfa (Gonal-F) (NCT03857230)
- 2019-06-10Results posted on the registry: Ferring Pharmaceuticals, highly purified human chorionic gonadotropin + recombinant human chorionic gonadotropin (NCT02449889)
- 2019-04-23Results posted on the registry: University of California, San Diego, Dexamethasone + recombinant human chorionic gonadotropin (r-hCG) (NCT01154192)
- 2019-03-08Also stopped (terminated): Mount Sinai Hospital, Canada, Nimodipine + Placebo (NCT01551368)
- 2019-01-14Phase 3 first posted: Centre Hospitalier Intercommunal Creteil, DUOSTIM + Conventional stimuli (NCT03803228)
- 2018-11-26Results posted on the registry: University Medical Centre Ljubljana, Elonva (NCT02606500)
- 2018-11-21Results posted on the registry: UConn Health, GnRH agonist + hCG (NCT01606709)
- 2018-11-21Also stopped (terminated): UConn Health, GnRH agonist + hCG (NCT01606709)
- 2018-11-15Phase 3 first posted: Instituto Valenciano de Infertilidad, IVI Alicante, Pre-treatment with rLH (Luveris 75 IU), (NCT03741699)
- 2018-09-14Also stopped (terminated): St. Olavs Hospital, fostimon + puregon (NCT01882166)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision